JiangXi Tianxin Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
JiangXi Tianxin Pharmaceutical has a total shareholder equity of CN¥4.4B and total debt of CN¥223.0M, which brings its debt-to-equity ratio to 5.1%. Its total assets and total liabilities are CN¥5.2B and CN¥895.0M respectively. JiangXi Tianxin Pharmaceutical's EBIT is CN¥488.4M making its interest coverage ratio -232.9. It has cash and short-term investments of CN¥2.4B.
Key information
5.1%
Debt to equity ratio
CN¥222.99m
Debt
| Interest coverage ratio | -232.9x |
| Cash | CN¥2.38b |
| Equity | CN¥4.35b |
| Total liabilities | CN¥895.05m |
| Total assets | CN¥5.25b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 603235's short term assets (CN¥3.2B) exceed its short term liabilities (CN¥508.9M).
Long Term Liabilities: 603235's short term assets (CN¥3.2B) exceed its long term liabilities (CN¥386.2M).
Debt to Equity History and Analysis
Debt Level: 603235 has more cash than its total debt.
Reducing Debt: 603235's debt to equity ratio has reduced from 23% to 5.1% over the past 5 years.
Debt Coverage: 603235's debt is well covered by operating cash flow (287.9%).
Interest Coverage: 603235 earns more interest than it pays, so coverage of interest payments is not a concern.